Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism

被引:52
作者
Buyske, S
Williams, TA
Mars, AE
Stenroos, ES
Ming, SX
Wang, R
Sreenath, M
Factura, MF
Reddy, C
Lambert, GH
Johnson, WG
机构
[1] Rutgers State Univ, Dept Stat & Genet, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Childhood Neurotoxicol & Exposure Assessment, Piscataway, NJ 08854 USA
[5] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pediat, Newark, NJ 07103 USA
[6] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA
关键词
D O I
10.1186/1471-2156-7-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Certain loci on the human genome, such as glutathione S-transferase M1 (GSTM1), do not permit heterozygotes to be reliably determined by commonly used methods. Association of such a locus with a disease is therefore generally tested with a case-control design. When subjects have already been ascertained in a case-parent design however, the question arises as to whether the data can still be used to test disease association at such a locus. Results: A likelihood ratio test was constructed that can be used with a case-parents design but has somewhat less power than a Pearson's chi-squared test that uses a case-control design. The test is illustrated on a novel dataset showing a genotype relative risk near 2 for the homozygous GSTM1 deletion genotype and autism. Conclusion: Although the case-control design will remain the mainstay for a locus with a deletion, the likelihood ratio test will be useful for such a locus analyzed as part of a larger case-parent study design. The likelihood ratio test has the advantage that it can incorporate complete and incomplete case-parent trios as well as independent cases and controls. Both analyses support ( p = 0.046 for the proposed test, p = 0.028 for the case-control analysis) an association of the homozygous GSTM1 deletion genotype with autism.
引用
收藏
页数:9
相关论文
共 29 条
[1]  
Alexandrie AK, 2004, CANCER EPIDEM BIOMAR, V13, P908
[2]   Analysis of autism susceptibility gene loci on chromosomes 1p, 4p, 6q, 7q, 13q, 15q, 16p, 17q, 19q and 22q in Finnish multiplex families [J].
Auranen, M ;
Nieminen, T ;
Majuri, S ;
Vanhala, R ;
Peltonen, L ;
Järvelä, I .
MOLECULAR PSYCHIATRY, 2000, 5 (03) :320-322
[3]   Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome [J].
Chacko, P ;
Joseph, T ;
Mathew, BS ;
Rajan, B ;
Pillai, AR .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2005, 581 (1-2) :153-163
[4]   Simultaneous characterization of glutathione S-transfersase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks [J].
Chen, CL ;
Liu, Q ;
Relling, MV .
PHARMACOGENETICS, 1996, 6 (02) :187-191
[5]  
Chen GK, 2006, MOL PSYCHIATR, V11, P214, DOI 10.1038/sj.mp.4001753
[7]  
Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239
[8]   GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population [J].
Hung, RJ ;
Boffetta, P ;
Brennan, P ;
Malaveille, C ;
Hautefeuille, A ;
Donato, F ;
Gelatti, U ;
Spaliviero, M ;
Placidi, D ;
Carta, A ;
di Carlo, AS ;
Porru, S .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (04) :598-604
[9]   Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism [J].
James, SJ ;
Cutler, P ;
Melnyk, S ;
Jernigan, S ;
Janak, L ;
Gaylor, DW ;
Neubrander, JA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (06) :1611-1617
[10]   Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity [J].
Kirk, GD ;
Turner, PC ;
Gong, YY ;
Lesi, OA ;
Mendy, M ;
Goedert, JJ ;
Halls, AJ ;
Whittle, H ;
Hainaut, P ;
Montesano, R ;
Wild, CP .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) :373-379